Clinical next-generation sequencing in patients with non-small cell lung cancer. (Q54313342)

27 May 2018

title

Clinical next-generation sequencing in patients with non-small cell lung cancer. (English)

1 reference

27 May 2018

1 reference

27 May 2018

Christina M. Lockwood

1 reference

27 May 2018

author name string

Siddhartha Devarakonda

1 reference

27 May 2018

David H Spencer

1 reference

27 May 2018

Kalin Guebert

1 reference

27 May 2018

Andrew J Bredemeyer

1 reference

27 May 2018

Hussam Al-Kateb

1 reference

27 May 2018

TuDung T Nguyen

1 reference

27 May 2018

Eric J Duncavage

1 reference

27 May 2018

Catherine E Cottrell

1 reference

27 May 2018

Shashikant Kulkarni

1 reference

27 May 2018

Rakesh Nagarajan

1 reference

27 May 2018

Karen Seibert

1 reference

27 May 2018

Maria Baggstrom

1 reference

27 May 2018

Saiama N Waqar

1 reference

27 May 2018

John D Pfeifer

1 reference

27 May 2018

Daniel Morgensztern

1 reference

27 May 2018

Ramaswamy Govindan

1 reference

27 May 2018

language of work or name

English

0 references

publication date

24 October 2014

1 reference

27 May 2018

published in

Cancer

1 reference

27 May 2018

volume

121

1 reference

27 May 2018

issue

1 reference

27 May 2018

page(s)

631-639

1 reference

27 May 2018

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29089

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29089

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29089

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29089

New targetable oncogenes in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29089

The Path to Personalized Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29089

Enabling personalized cancer medicine through analysis of gene-expression patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29089

Personalized medicine and development of targeted therapies: The upcoming challenge for diagnostic molecular pathology. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29089

Comprehensive genomic characterization of squamous cell lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29089

Somatic mutations affect key pathways in lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29089

A high-dimensional, deep-sequencing study of lung adenocarcinoma in female never-smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29089

Design of targeted, capture-based, next generation sequencing tests for precision cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29089

Validation of a next-generation sequencing assay for clinical molecular oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29089

Detection of gene rearrangements in targeted clinical next-generation sequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29089

Detection of structural DNA variation from next generation sequencing data: a review of informatic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29089

Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29089

Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29089

Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29089

A pilot study using next-generation sequencing in advanced cancers: feasibility and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29089

Comparison of targeted next-generation sequencing (NGS) and real-time PCR in the detection of EGFR, KRAS, and BRAF mutations on formalin-fixed, paraffin-embedded tumor material of non-small cell lung carcinoma-superiority of NGS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29089

Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29089

Targeted sequencing of cancer-related genes in colorectal cancer using next-generation sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29089

Detection of FLT3 internal tandem duplication in targeted, short-read-length, next-generation sequencing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29089

21 January 2018

Identifiers

DOI

10.1002/CNCR.29089

1 reference

27 May 2018

1 reference

27 May 2018